Results 51 to 60 of about 4,765 (162)

A Systematic Review of Cannabidiol Based Dosage Forms

Precision Nanomedicine, 2021
This review article provides a comprehensive overview and analysis of current and experi-mental cannabidiol (CBD) delivery methods and examines the pharmacological significance of various dosage forms and delivery systems.
Alexander J. Sperry, Tarik Youssef, Yen Tuong, Abhay S. Chauhan   +3 more
doaj   +1 more source

Cannabidiol in Anorexia Nervosa: A Double‐Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change

International Journal of Eating Disorders, Volume 59, Issue 7, Page 1576-1587, July 2026.
ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder marked by an intense fear of gaining weight and persistent body dissatisfaction, both during periods of underweight and after weight restoration. The endocannabinoid system may offer therapeutic benefits, particularly in reducing anxiety.
Neha Sahota, David J. Grelotti, Tyler Nguyen, Walter H. Kaye, Skylar Swindle, Raymond Suhandynata, Spencer Seely, Megan E. Shott, Guido K. W. Frank   +8 more
wiley   +1 more source

Dronabinol Is Not a Game Changer in Pediatric Palliative Care: Results from a Retrospective Study

Children
Background/Objectives: Patients with life-limiting conditions (LLCs) often suffer from restlessness, spasticity, pain, and seizures. Dronabinol (DRB) may have a relieving effect; however, data on the effectiveness of DRB in children with LLCs are limited
Holger Hauch, Annika Lisakowski, Julia Wager, Boris Zernikow   +3 more
doaj   +1 more source

Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry

Journal of Pain Research, 2022
Michael A Ueberall,1 Ute Essner,2 Carlos Vila Silván,3 Gerhard HH Mueller-Schwefe4 1Center of Excellence in Health Care Research of the German Pain Association, Institute of Neurological Sciences, Nuernberg, Germany; 2Medical Department, O.
Ueberall MA, Essner U, Vila Silván C, Mueller-Schwefe GHH   +3 more
doaj  

International Policy Approaches for Higher THC Cannabis Products: Are They Applicable to the Australian Medicinal Cannabis Framework?

Drug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction There have been concerted research efforts internationally to examine the health effects of higher delta‐9‐tetrahydrocannabinol (THC) concentration cannabis products and to design policies to reduce potential negative health effects of their use.
Myfanwy Graham, Dereje Assefa, Adrian Carter, Suzanne Nielsen   +3 more
wiley   +1 more source

Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS

HIV/AIDS: Research and Palliative Care, 2016
Melissa E Badowski,1 Sarah E Perez2 1Department of Pharmacy Practice, Section of Infectious Diseases Pharmacotherapy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA; 2Infectious Diseases Clinic, Tufts Medical Center, Boston, MA,
Badowski ME, Perez SE
doaj  

Management Approach for Anorexia in Palliative Care: An Integrative Literature Review / Condutas para o Manejo da Anorexia em Cuidados Paliativos: Revisão Integrativa

Revista de Pesquisa Cuidado é Fundamental Online, 2020
Objetivo: Identificar as evidências científicas acerca das condutas para o manejo da anorexia em cuidados paliativos. Métodos: Trata-se de uma revisão integrativa, cujo levantamento bibliográfico dos dados deu-se através da pesquisa em quatro bases de ...
Raquel Bezerra Barbosa de Moura, Ângelo Brito Pereira de Melo, Thamires Ribeiro Chaves, Luciana Maria Martinez Vaz, Janine Maciel Barbosa, Renan Gondim Araújo   +5 more
doaj   +1 more source

A Feasibility Assessment of the FDA Adverse Event Reporting System for the Detection of Cannabis‐Related Safety Signals

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 6, June 2026.
ABSTRACT Background The applicability of spontaneous reporting systems such as the US Food and Drug Administration Adverse Event Reporting System (FAERS) to detect cannabis‐related safety signals remains unclear due to the potential for discrepant reporting patterns between pharmaceutical and non‐pharmaceutical cannabis‐derived products (CDPs ...
Priscilla O. M. V. Lopes, Cory S. Harris, Christopher A. Gravel   +2 more
wiley   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1287-1308, May 2026.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source

Cannabinoides en porros de resina de cannabis decomisados en Castilla y León

Anales del Sistema Sanitario de Navarra
Fundamento. El cannabis, en sus productos hierba y resina, es la droga ilegal más consumida en el mundo. El objetivo del estudio es conocer la riqueza y disponibilidad de los principales cannabinoides en la resina de cannabis en los porros circulantes a ...
Eduardo Tejedor-Tejada, Jesús Miguel Tejedor Muñoz   +1 more
doaj   +1 more source